Authors Rayyan Zafar, Anne Schlag, Lawrence Phillips, David J Nutt Published December 15, 2021 We previously reported on the legalisation of medical cannabis in the UK which was catalysed by…

Authors Anne K Schlag, Jacob Aday, Iram Salam, Jo C Neill, David J Nutt Published February 3, 2022 Psychedelic medicines are a rapidly developing area of clinical research and public…

Authors Gillian W Shorter, Magdalena Harris, Andrew McAuley, Kirsten MA Trayner, Alex Stevens Published May 4, 2022 Background The United Kingdom (UK) is currently experiencing a public health crisis of…

Authors Anne Katrin Schlag, Michael Lynskey, Alan Fayaz, Alkyoni Athanasiou-Fragkouli, Brigitta Brandner, Barbara Haja, Elizabeth Iveson and David J. Nutt Published June 14, 2022 Medical Cannabis for Chronic Pain Chronic…

Authors Stephanie Bourke, Anne Schlag, Saoirse Elizabeth O’Sullivan, David Nutt, David Finn Published May 21, 2022 Fibromyalgia affects millions of people worldwide and has a significant impact on quality of…

Authors Robin Carhart-Harris, David Nutt Published July 30, 2010 Abstract This study used a web-based questionnaire to investigate user perceptions of the benefits and harms of hallucinogenic drug use. Over…

Authors Anne Katrin Schlag, Rayyan Zafar, Michael Lynskey, Lawrence D Phillips, Alkyoni Athanasiou-Fragkouli, David J Nutt Published November 3rd, 2022 Randomised controlled trials (RCTs) have long been considered the ‘gold…

An observational study of patients prescribed medicinal Cannabis for chronic pain, anxiety, posttraumatic stress disorder and multiple sclerosis Authors Kylie O’Brien, Justin Beilby, Michelle Frans, Michael Lynskey, Michael Barnes, Mihindu…

Authors Balázs Szigeti, Lawrence D. Phillips and David Nutt Published July 17, 2023 Background The two pillars of modern medical research are where in most randomized controlled trials (RCTs), the…